Our Pricing

Understanding Mounjaro BMI 28 Eligibility and Your Discount Code

Published on: June 03, 2026

Searching for a mounjaro bmi 28 discount code uk offer? At Cured Pharmacy, eligible patients receive £20 off their first Mounjaro order, with prices starting from £124.99. Our UK-registered prescribers assess your suitability during a free online consultation, ensuring you meet the clinical criteria for this advanced weight loss treatment.

Who Qualifies for Mounjaro at BMI 28?

In the UK, Mounjaro (tirzepatide) is licensed for adults with a body mass index of 30 or above, or 27 and above if you have at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. However, clinical guidelines recognise that patients with a BMI of 28 may qualify if they present with significant comorbidities or metabolic risk factors that would benefit from pharmacological intervention.

During your consultation at Cured Pharmacy, our UK prescribers evaluate your full medical history, current medications, and weight-related health concerns. If your BMI is 28 with relevant comorbidities, you may be considered suitable for Mounjaro treatment subject to prescriber approval. This individualised assessment ensures the medication is both safe and clinically appropriate for your circumstances.

The MHRA-approved prescribing criteria prioritise patient safety above all else. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees every prescription to ensure it meets UK regulatory standards and aligns with NICE guidance on obesity management.

How Mounjaro Delivers Superior Weight Loss Results

Patients typically begin with a 2.5mg weekly injection, with doses gradually increased every four weeks to minimise gastrointestinal side effects. The maintenance dose ranges from 5mg to 15mg depending on individual tolerance and clinical response, as determined by your UK prescriber.

Mounjaro works by slowing gastric emptying, enhancing feelings of fullness after meals, and reducing hunger signals between meals. These physiological changes make it easier to adhere to a reduced-calorie diet without experiencing the intense cravings that often derail weight loss efforts [1].

The Dual-Agonist Mechanism

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for weight management [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing synergistic effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than results observed with semaglutide-based therapies [1][2]. These outcomes represent the highest efficacy data for any approved weight loss medication to date.

Applying Your Mounjaro BMI 28 Discount Code

To access your discount, complete the free online consultation on our website. The assessment takes under three minutes and covers your medical history, current medications, weight loss goals, and any existing health conditions. A UK-registered prescriber reviews your responses within hours, and if approved, your Mounjaro prescription is issued and dispensed from our GPhC-registered pharmacy.

All Mounjaro orders are dispatched in 100% discreet packaging with tracked delivery. Your medication arrives with full patient information leaflets, injection technique guidance, and access to our clinical team for ongoing support throughout your treatment.

How to Redeem Your £20 discount

Your £20 discount applies automatically to your first Mounjaro order at Cured Pharmacy once your prescription is approved. There's no need to enter a separate code at checkout — the saving is reflected in your final price before payment.

With this discount, your starting dose of Mounjaro 2.5mg costs less than typical market rates, making your initial month of treatment more affordable as you begin your weight loss journey. Transparent pricing means you'll see the exact cost before completing your clinical consultation, with no hidden fees or surprise charges.

Mounjaro vs Other Weight Loss Treatments

While several prescription weight loss medications are available in the UK, they differ significantly in mechanism, efficacy, and administration method. Understanding these differences helps you and your prescriber choose the most suitable option for your individual circumstances.

Injectable GLP-1 receptor agonists like Wegovy and Saxenda work through single-pathway mechanisms, whereas Mounjaro's dual-agonist action produces greater average weight loss in head-to-head trials [1][2]. Oral medications such as Orlistat and Mysimba offer non-injectable alternatives but typically achieve more modest weight reductions compared to newer injectable therapies.

Your UK prescriber considers factors including your BMI, weight loss goals, medical history, injection tolerance, and budget when recommending treatment. Some patients prefer daily injections with lower upfront costs, whilst others prioritise once-weekly convenience and maximum efficacy despite higher prices.

Expected Results and Timeline with Mounjaro

Most patients notice reduced appetite and smaller portion sizes within the first week of starting Mounjaro. These early changes make it easier to adopt healthier eating patterns without feeling deprived or excessively hungry between meals.

Your prescriber may schedule follow-up consultations every 8-12 weeks to monitor your progress, adjust your dose if needed, and address any side effects. Ongoing clinical supervision ensures you're achieving optimal results whilst maintaining safety throughout your treatment journey.

What Clinical Trials Show

In the SURMOUNT clinical trial programme, participants lost an average of 5-7% of their body weight during the first 12 weeks on Mounjaro, with weight loss continuing progressively as doses increased [1]. By week 72, those on the 15mg maintenance dose had achieved average reductions exceeding 20% of their starting weight.

Individual results vary based on adherence to the prescribed dose, dietary modifications, physical activity levels, and metabolic factors. Some patients experience rapid initial weight loss during the first month, whilst others see more gradual but sustained reductions over several months.

Managing Side Effects and Maximising Success

Staying well-hydrated is essential, particularly if you experience diarrhoea or reduced fluid intake due to decreased appetite. Aim for at least two litres of water daily, and contact your prescriber if you develop signs of dehydration such as dizziness, dark urine, or persistent headaches.

Rare but serious side effects include pancreatitis, gallbladder problems, and thyroid tumours (observed in animal studies but not confirmed in humans) [1]. Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or a lump in your neck. Your UK prescriber will screen for contraindications during your consultation to minimise these risks.

Common Side Effects and How to Minimise Them

The most frequently reported side effects of Mounjaro are gastrointestinal symptoms including nausea, diarrhoea, constipation, and reduced appetite [1]. These effects are typically mild to moderate and diminish as your body adjusts to the medication over the first 4-8 weeks.

Starting at the lowest dose (2.5mg) and increasing gradually every four weeks allows your digestive system to adapt, significantly reducing the likelihood of severe nausea or vomiting. Eating smaller, more frequent meals and avoiding high-fat foods can further minimise gastrointestinal discomfort during the initial titration phase.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication and individual results may vary. Always consult a qualified healthcare professional before starting any new medication or weight loss programme.